Acadia Pharmaceuticals Inc
ACAD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070494
In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 353 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.
Members of Congress who traded ACAD
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 2
- Filings
- 2
- Members
- 1
- Buys / sells
- 0 / 2
- Estimated volume
- $16.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Chris JacobsRepublican · House · NY | 2 | 0 / 2 | $16.0K | Jun 16, 2022 | Jul 28, 2022 |
Trades
Every reported trade in Acadia Pharmaceuticals Inc, newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Chris JacobsRepublican · House · NY | ACADACADIA Pharmaceuticals Inc. | Sell | Self | Jun 16, 2022 | Jul 28, 2022 | 42 days | $1K-$15K | Filing |
| Chris JacobsRepublican · House · NY | ACADACADIA Pharmaceuticals Inc. | Sell (partial) | Self | Sep 8, 2020 | Nov 6, 2020 | 59 daysLate | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.